Dose equivalents in opioid substitution treatment

International Journal of Drug Policy

Volumn 13, Issue 6, 2002, Pages 445-447

  Carnwath, Tom ^a   Merrill, John ^b  

^a Substance Misuse Services   (United Kingdom)

^b GREATER MANCHESTER MENTAL HEALTH NHS FOUNDATION TRUST   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

BUPRENORPHINE; CODEINE PHOSPHATE; DIAMORPHINE; METHADONE; MORPHINE SULFATE; OPIATE;

ANAMNESIS; DETOXIFICATION; DRUG EFFICACY; DRUG MEGADOSE; DRUG WITHDRAWAL; EDITORIAL; HUMAN; INTOXICATION; PRESCRIPTION; PRIORITY JOURNAL; SUBSTITUTION THERAPY; UNITED STATES; WITHDRAWAL SYNDROME;

EID: 0036900983     PISSN: 09553959     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0955-3959(02)00073-7     Document Type: Editorial

References (26)

1. Ball J., Ross A. The effectiveness of methadone maintenance treatment. 1991;Springer, New York.
2. Beschner G.M., Walters J.M. Just another habit? The heroin users' perspective on treatment. Hanson B., Beschner G., Walters J.M., Bovelle E. Life with heroin: voices from the inner city. 1985;Lexington Books, Lexington.
3. Carvey P.M. Drug action in the central nervous system. 1998;Oxford University Press, Oxford.
4. Medical co-prescription of heroin: two randomised controlled trials. 2002;CCBH, Utrecht.
5. Drug misuse and dependence. Guidelines on clinical management. 1991;HMSO, London.
6. Drug misuse and dependence. Guidelines on clinical management. 1999;The Stationery Office, London.
7. Felder C., Uehlinger C., Baumann P., Powell K., Eap C.B. Oral and intravenous methadone use: some clinical and pharmacokinetic aspects. Drug and Alcohol Dependence. 55:1999;137-143.
8. Fischer G., Jagsch R., Eder H., Gombas W., Etzersdorfew P., Schmimmohl K., Schatten C., Weninger M., Aschauer H. Comparison of methadone and slow-release morphine maintenance in pregnant addicts. Addiction. 94:1999;231-239.
9. Gossop M., Marsden J., Stewart D., Rolfe A. Patterns of improvement after methadone treatment: 1 year follow up results from the National Treatment Outcome Research Study (NTORS). Drug and Alcohol Dependence. 60:2000;275-286.
10. Hartnoll R.L., Mitcheson M., Battersby M., Brown G., Ellis M., Fleming P., Hedley N. Evaluation of heroin maintenance in controlled trial. Archives of General Psychiatry. 37:1980;877-884.
11. Huizer H. Analytical studies on illicit heroin. V. Efficacy of volatilisation during heroin smoking. Pharmaceutisch Weekblad (Scientific Edition). 9:1987;203-211.
12. Hunt D.E., Lipton D.S., Goldsmith D.S., Strug D.L., Spunt B. "It takes your heart": The image of methadone maintenance in the addict world and its effect on recruitment into treatment. International Journal of the Addictions. 20:1986;1751-1771.
13. Jaffe J.H., Martin W.R. Opioid analgesics and antagonists. Gilman A.G., Rall T.W., Nies A.S., Tayler P. The pharmacological basis of therapeutics. 1990;Pergamon, New York.
14. King L.A. Drug content of powders and other illicit preparations in the UK. Forensic Science International. 85:1997;35-147.
15. Krausz M., Verthein U., Degkwitz P., Haasen C., Raschke P. Maintenance treatment of opiate addicts in Germany with medications containing codeine - results of a follow-up study. Addiction. 93:1998;1161-1167.
16. Ladewig D., Kury P. Heroin substitution trials in Switzerland-context, preliminary data and findings from an evaluation perspective. Bammer G. International perspectives on the prescription of heroin to dependent users: a collection of papers from the United Kingdom, Switzerland, the Netherlands and Australia. 1997;Australian Institute of Criminology, Sydney.
17. McCusker C., Davis M. Prescribing drug of choice to illicit heroin users: the experience of a UK Community Drug Team. Journal of Substance Abuse Treatment. 13:1996;521-531.
18. Metrebian N., Stimson G. Heroin prescribing in the UK: lost opportunities for research. Addiction Research. 8:2000;305-310.
19. Metrebian N., Shanahan W., Wells B., Stimson G. Feasibility of prescribing injectable heroin and methadone to opiate-dependent drug users: associated health gains and harm reductions. The Medical Journal of Australia. 168:1998;596-600.
20. Metrebian, N., Carnwath, T., Storz, T., & Stimson, G. (2001). A survey of U.K. heroin prescribers. Presentation to International Conference on Harm Reduction, New Delhi, India.
21. Scott J., Winfield A., Kennedy E., Bond C. Laboratory study of the effects of citric and ascorbic acids on injections prepared with brown heroin. International Journal of Drug Policy. 11:2000;417-422.
22. Seidenberg S.A., Honegger U. Methadon, heroin und andere opioide-medizinisches Manual für die ambulante opioidgestützte Behandlung [Methadone, Heroin and other Opiods-Medical Manual for Outpatient Opioid-supported Treatment]. 1998;Verlag Hans Huber, Bern.
23. Sell L., Farrell M., Robson P. Diamorphine, dipipanone and cocaine in England and Wales. Drug and Alcohol Review. 16:1997;221-226.
24. Strain E.C., Stitzer M.L., Liebson I.A., Bigelow G.E. Methadone dose and treatment outcome. Drug and Alcohol Dependence. 33:1993;105-117.
25. Strang J., Sheridan J., Barber N. Prescribing injectable and oral methadone to opiate addicts: results from the 1995 national postal survey of community pharmacies in England and Wales. British Medical Journal. 313:1996;270-272.
26. Zunzunegui M. Es la prescripcion medica de la heroina una opcion de tratamiento para la addicion a la heroina? Equipo PEPSA (Programa Experimental de Prescripcion de Estupefacientes en Andalucia. [Is the medical prescription of heroin a treatment option for heroin addiction? The PEPSA Team (The Experimental Program of Narcotic Prescription in Andalucia)]. Medicina Clinica. 113:1999;219-221.